Why VERDESO® Foam?
VERDESO® Foam effectively relieves itchy and inflamed skin
- VERDESO® Foam substantially reduced erythema, induration/papulation, scaling, lichenification, and oozing/crusting vs vehicle foam.2
- VERDESO® Foam significantly reduced pruritus vs vehicle foam (67% vs 26%; P<0.0001).2†
VERDESO® Foam is safe and well-tolerated
- Well tolerated in patients 3 months of age or older when applied BID for 4 weeks in clinical studies.2
- 3% of patients experienced application site burning (N=387).2
- Minimal skin irritation and low systemic absorption.2
- VERDESO® Foam offers the trusted safety of desonide 0.05%.
VERDESO® Foam is the only low-potency steroid delivered in a new patient-preferred foam vehicle
- More than 70% of patients surveyed* reported a preference for VERDESO® Foam vs other topical medications.1
- Patients prefer VERDESO® Foam because it is easy to use, leaves skin feeeling soft, disappears quickly into the skin, and can be easily applied to a large body area.*1
Patient Compliance
VERDESO® Foam may improve patient compliance because of its innovative VersaFoam-EF™ vehicle.2
†Based on the proportion of subjects who had a pruritus score of 0 (no itching) or 1 (minimal itching) at Week 4.
* A patient post-study questionnaire (N=581) was administered at the Week 4 evaluation during the phase 3 clinical trial to determine patient preferences regarding topical medications.